Pediatric non-Hodgkin lymphoma encompasses a diverse group of malignancies distinct from the adult forms of the disease. Early recognition and accurate diagnosis of NHL in children are crucial, as these factors significantly influence treatment approaches and prognostic outcomes. Radiologic assessment plays a pivotal role in this context, with various imaging modalities such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) being utilized to identify tumors and other related manifestations. Moreover, this review meticulously presents the visual aspects of these modalities, serving as a guide for healthcare professionals.

One notable aspect of pediatric NHL is its varied presentations, which can complicate its diagnosis. Unlike adults, where organ-specific symptoms may dominate, children may exhibit nonspecific signs. Symptoms such as fatigue, fever, and generalized lymphadenopathy often predominate. The review discusses the importance of recognizing these signs early on, suggesting that timely imaging studies can lead to quicker diagnosis and intervention, significantly enhancing patient outcomes.

The authors further elucidate the imaging characteristics of different subtypes of pediatric NHL, breaking down the typical appearances seen in various imaging modalities. For instance, CT scans often highlight enlarged lymph nodes in conventional areas, such as the cervical region, abdomen, and mediastinum, which are crucial for staging. MRI is especially useful in the assessment of central nervous system involvement, which can occur more frequently in pediatric cases, necessitating a comprehensive understanding of these features by radiologists.

In terms of ultrasound, the review indicates that this modality can provide rapid, bedside solutions for initial evaluations. The non-invasive nature and accessibility of ultrasound make it an excellent first-line tool for assessing lymphadenopathy in children. Dasic et al. highlight how this can be particularly beneficial in a pediatric setting, where concerns about radiation exposure are paramount. The review further details the sonographic characteristics found in lymphomas, allowing clinicians to differentiate them from benign lymphadenopathy and other potential diagnoses.

An essential aspect addressed in the review is the role of advanced imaging techniques, such as PET-CT, in the staging of pediatric NHL. Positron emission tomography combined with computed tomography provides unique metabolic information that can aid in assessing disease activity and treatment response. The incorporation of metabolic imaging is a significant advancement, giving clinicians a clearer understanding of tumor dynamics and their implications for prognosis and therapy.

Furthermore, Dasic et al. provide a critical overview of the complications associated with pediatric non-Hodgkin lymphoma. This includes the risk of infectious complications due to immune suppression from both the disease and its treatments. The imaging characteristics of such complications, whether they arise from neutropenic fever or cytotoxic therapy, are essential considerations that the authors meticulously outline, underscoring the need for vigilance in monitoring these at-risk patients.

An additional unique feature of this pictorial review is its focus on the differential diagnosis. The authors guide the readers through a range of conditions that may mimic or present similarly to pediatric NHL. This is particularly relevant, as misdiagnosis can lead to delays in treatment and unfavorable outcomes. By discussing entities such as infections, autoimmune disorders, and other malignancies, the review underscores the importance of a careful and methodical approach to pediatric imaging.

Another compelling angle presented is the imaging follow-up protocols for children diagnosed with NHL. Regular imaging is crucial to monitor response to treatment and detect any recurrence. The authors provide evidence-based recommendations for the frequency and type of imaging necessary at various stages of follow-up. Such insights are invaluable, as they can help streamline care pathways and reassure both patients and parents in what can be an emotionally challenging time.

Ultimately, the advent of this pictorial review marks a significant milestone in the ongoing effort to enhance the diagnostic capabilities of pediatricians and radiologists alike. By combining clinical insights with a rich array of imaging visuals, Dasic et al. equip medical professionals with the tools necessary to recognize and manage pediatric non-Hodgkin lymphoma effectively. This is not just an academic resource; it represents a lifeline for countless young patients navigating the complexities of cancer treatment.

In conclusion, the research not only highlights the significance of imaging in pediatric non-Hodgkin lymphoma but also urges further exploration into this vital area of pediatric oncology. With ongoing advancements in imaging technologies and methodologies, the potential to improve diagnostic accuracy and patient outcomes is immense. As the field continues to evolve, such comprehensive reviews will remain essential, guiding future research and clinical practices in the fight against childhood cancer.

Subject of Research: Pediatric Non-Hodgkin Lymphoma Imaging

Article Title: Imaging findings in pediatric non-Hodgkin lymphoma: a pictorial review

Article References:

Dasic, I., Littooij, A., Tolboom, N. et al. Imaging findings in paediatric non-Hodgkin lymphoma: a pictorial review. Pediatr Radiol (2025). https://doi.org/10.1007/s00247-025-06396-y

Image Credits: AI Generated

DOI: 13 November 2025

Keywords: Pediatric non-Hodgkin lymphoma, imaging findings, pediatric radiology, CT, MRI, ultrasound, PET-CT, differential diagnosis, oncology, treatment response.

Burkitt lymphoma, an aggressive B cell non-Hodgkin lymphoma, accounts for one of the most common childhood cancers in malaria-endemic regions, yet it is comparatively rare worldwide. The spatial correlation with persistent P. falciparum transmission has long suggested that the parasite plays a pivotal role in triggering oncogenic processes within the immune system. Unlike other Plasmodium species responsible for malaria, only P. falciparum is correlated with the pathogenesis of BL, indicating a unique pathogenic mechanism specific to this species.

Central to the study’s findings is the heightened and sustained expression of activation-induced cytidine deaminase (AID) in B lymphocytes of children infected with P. falciparum. AID is an enzyme crucial for somatic hypermutation and class-switch recombination in antibody genes—processes necessary for antibody diversity during normal immune responses. However, dysregulated or excessive AID activity can induce off-target mutations and chromosomal translocations, which are hallmarks of lymphomagenesis. This dysregulation emerged as a plausible molecular conduit linking malaria infection to malignant transformation.

The hallmark genetic event in Burkitt lymphoma is the translocation of the MYC oncogene, primarily involving a chromosomal rearrangement where the MYC gene is aberrantly juxtaposed to immunoglobulin gene loci. This translocation results in the dysregulated expression of MYC, a powerful driver of cellular proliferation and transformation. Importantly, AID is indispensable for initiating these translocations by introducing DNA breaks in immunoglobulin genes. The sustained elevation and functionality of AID in the B cells of malaria-infected children thus provide direct mechanistic evidence explaining how P. falciparum infection may potentiate MYC translocations and subsequent lymphoma development.

The investigators employed rigorous immunological assays on blood samples drawn from Kenyan children diagnosed with uncomplicated malaria, characterized clinically by fever, headache, and other non-specific symptoms without severe organ failure. Comparisons were made with age-matched controls free of malaria infection. The results revealed a significant increase in AID transcript levels and enzymatic activity exclusively in the infected cohorts, confirming not only increased expression but also the operational integrity of AID in the context of malaria infection.

This hyperactivation of AID highlights the complex role of the immune response in malaria pathogenesis. While the immune system attempts to combat the parasite, the chronic stimulation and cellular stress within B cells may drive aberrant genetic alterations, thereby increasing the risk for the development of malignant clones. This dualistic nature of AID—critical for immunity yet potentially oncogenic when dysregulated—emphasizes the delicate balance the immune system must maintain during persistent infectious challenges.

The discovery has profound implications for public health, particularly in malaria-endemic regions where both diseases impose substantial morbidity and mortality. Strategies aimed at reducing the burden of P. falciparum malaria through vector control, vaccination, and effective antimalarial therapies might not only curb malaria transmission but could also have the ancillary benefit of lowering the incidence of BL. This adds a compelling dimension to malaria prevention efforts, highlighting oncological outcomes alongside infectious disease control.

Moreover, the study opens avenues to explore whether AID dysregulation induced by chronic P. falciparum infection might contribute to other B cell malignancies. Given the enzyme’s crucial role in antibody diversification and the known links between infections and non-Hodgkin lymphomas, there is considerable interest in understanding whether similar mechanisms operate in other contexts. Elucidating these pathways could guide the development of targeted interventions aimed at mitigating lymphomagenesis in vulnerable populations.

Dr. Rosemary Rochford, who led the research team at the University of Colorado Anschutz School of Medicine, emphasized the transformative nature of these findings. She noted that identifying AID’s role offers a tangible molecular target for future therapies designed to disrupt the oncogenic sequelae of malaria infection. Such interventions could potentially intercept lymphomagenesis prior to clinical manifestation, representing a paradigm shift in cancer prevention rooted in infectious disease biology.

The team is continuing to investigate additional impacts of chronic P. falciparum infection on immune cell function and genetic stability. This includes exploring how malaria-induced immune modulation may create an environment that facilitates not just AID-mediated mutation but also immune evasion, clonal expansion, and eventual malignant transformation. These ongoing efforts aim to provide a comprehensive picture of the immunopathology linking infectious agents with cancer.

In sum, this landmark study not only confirms the long-suspected causal relationship between P. falciparum infection and Burkitt lymphoma but also elucidates the enzymatic and genetic underpinnings that drive this association. By pinpointing AID as a key mediator, the research bridges a critical knowledge gap and lays the foundation for novel diagnostic and therapeutic strategies. These insights underscore the intrinsic connections between infectious diseases and cancer, highlighting the importance of multidisciplinary approaches in addressing global health challenges.

For scientists and public health officials alike, these findings represent a clarion call to intensify efforts in malaria eradication and to consider oncological outcomes in infectious disease research. The intricate dance between a parasite and the host immune system can dictate not only immediate disease but also long-term oncogenic risk, demonstrating that conquering one illness may safeguard against another. As such, malaria control transcends infection alone, with the promise of reducing cancer risk in some of the world’s most vulnerable populations.

Subject of Research: Role of Plasmodium falciparum malaria infection in the molecular pathogenesis of childhood Burkitt lymphoma through sustained AID expression in B cells.

Article Title: Sustained activation induced cytidine deaminase (AID) expression in B cells following Plasmodium falciparum malaria infection in Kenyan children

News Publication Date: 14-Mar-2025

Web References:

• The Journal of Immunology article
• AAI News coverage

References:
10.1093/jimmun/vkaf005

Keywords:
Burkitt lymphoma, P. falciparum malaria, activation-induced cytidine deaminase, AID, MYC translocation, B cell lymphoma, childhood cancer, Plasmodium infections, hematologic malignancy, non-Hodgkin lymphoma, immune dysregulation, Kenyan children